Apotex Inc v Sanofi-Synthelabo Canada Inc
id:
apotex-inc-v-sanofi-synthelabo-canada-inc-306-9249071
title:
Apotex Inc v Sanofi-Synthelabo Canada Inc
text:
Apotex Inc v Sanofi-Synthelabo Canada Inc, [2008] 3 S.C.R. 265, is a leading Supreme Court of Canada decision on the novelty and non-obviousness requirements for a patent in Canada. The Court rejected a challenge by the generic drug manufacturer Apotex to declare Synthelabo Canada's patent for Plavix, an anti-coagulant drug, invalid. At issue was whether selection patents are invalid in principle, and if they are not, whether the subject selection patent was invalid on the grounds of anticipatio
brand slug:
wiki
category slug:
encyclopedia
description:
Supreme Court of Canada case
original url:
https://en.wikipedia.org/wiki/Apotex_Inc_v_Sanofi-Synthelabo_Canada_Inc
date created:
date modified:
2022-11-20T00:50:00Z
main entity:
{"identifier":"Q4780733","url":"https://www.wikidata.org/entity/Q4780733"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/f/fb/Supreme_court_of_Canada_in_summer.jpg","width":4000,"height":2360}
fields total:
13
integrity:
15